1. Home
  2. SHOP vs NVO Comparison

SHOP vs NVO Comparison

Compare SHOP & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shopify Inc.

SHOP

Shopify Inc.

N/A

Current Price

$146.91

Market Cap

186.7B

Sector

Technology

ML Signal

N/A

Logo Novo Nordisk A/S

NVO

Novo Nordisk A/S

N/A

Current Price

$40.61

Market Cap

199.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SHOP
NVO
Founded
2004
1923
Country
Canada
Denmark
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
186.7B
199.4B
IPO Year
2014
2001

Fundamental Metrics

Financial Performance
Metric
SHOP
NVO
Price
$146.91
$40.61
Analyst Decision
Buy
Hold
Analyst Count
55
14
Target Price
★ $177.29
$45.74
AVG Volume (30 Days)
8.4M
★ 8.6M
Earning Date
11-03-2026
11-04-2026
Dividend Yield
N/A
★ 3.12%
EPS Growth
N/A
★ N/A
EPS
★ 1.06
N/A
Revenue
★ $11,556,000,000.00
N/A
Revenue This Year
$32.51
N/A
Revenue Next Year
$26.40
$1.30
P/E Ratio
$141.14
★ $13.60
Revenue Growth
★ 30.14
N/A
52 Week Low
$94.00
$35.12
52 Week High
$180.88
$64.16

Technical Indicators

Market Signals
Indicator
SHOP
NVO
Relative Strength Index (RSI) 42.76 52.44
Support Level $139.89 $37.61
Resistance Level $155.55 $41.41
Average True Range (ATR) 7.62 0.78
MACD -2.16 0.24
Stochastic Oscillator 31.96 49.53

Price Performance

Historical Comparison
SHOP
NVO

About SHOP Shopify Inc.

Shopify offers an e-commerce platform primarily to small and medium-size businesses. The firm has two segments. The subscription solutions segment allows Shopify merchants to conduct e-commerce on a variety of platforms, including the company's website, physical stores, pop-up stores, kiosks, social networks (Facebook), and Amazon. The merchant solutions segment offers add-on products for the platform that facilitate e-commerce and include Shopify Payments, Shopify Shipping, and Shopify Capital.

About NVO Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Share on Social Networks: